The Impact of Antiretroviral Drugs on HBV Infection
Oluwaseun O. Falade-Nwulia, MD, MPH
Assistant Professor of Medicine, Division of Infectious Diseases
Johns Hopkins University School of Medicine, Baltimore, MD
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2016. All rights reserved.
Oluwaseun (Seun) Falade-Nwulia is an Assistant Professor at the Johns Hopkins University School of Medicine and in the recent past was also Medical Director of the Baltimore City Health Department HIV Early Intervention Initiative and Direct Observed Therapy Programs. She also provides clinical care to HIV and hepatitis C infected patients at the Johns Hopkins Hospital. In the last 3 years, Seun has focused her clinical and academic pursuits on educating clinicians and public health practitioners about STDs, HIV, and hepatitis. Her research has focused on understanding the distribution and impact of hepatitis B and C in at risk populations. She is also actively involved in research aimed at improving HIV and hepatitis C testing, access to and retention in care in for both HIV and hepatitis in medically underserved communities.
At the completion of this educational session, learners will:
- Understand the epidemiology of HBV infection.
- Know the impact of HIV infection on HBV-related liver outcomes.
- Be aware of the impact of antiretroviral drugs on HBV.
- Have a better understanding of HBV in MSM with, and at risk for, HIV-infection.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
